LivaNova PLC Payments for Restructuring
LivaNova PLC (LIVN) reported Payments for Restructuring of $2.43 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-02-25
- LivaNova PLC payments for restructuring for the quarter ending 2024-12-31 was $1.79M.
- LivaNova PLC payments for restructuring for the quarter ending 2024-09-30 was $1.47M.
- LivaNova PLC payments for restructuring for the quarter ending 2024-06-30 was $5.10M.
- LivaNova PLC payments for restructuring for the quarter ending 2024-03-31 was $3.31M.
- LivaNova PLC payments for restructuring for fiscal 2025 was $2.43M, a 79.19% decline from fiscal 2024.
- LivaNova PLC payments for restructuring for fiscal 2024 was $11.66M, a 458.04% increase from fiscal 2023.
- LivaNova PLC payments for restructuring for fiscal 2023 was $2.09M, a 61.31% decline from fiscal 2022.
- LivaNova PLC payments for restructuring for fiscal 2022 was $5.40M, a 64.39% decline from fiscal 2021.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.43M 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.26M derived: sum of 2 quarters · filed 2026-02-25 | $8.35M derived: sum of 3 quarters · filed 2026-02-25 | $11.66M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $6.56M derived: sum of 2 quarters · filed 2024-10-31 | $9.87M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $5.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $8.41M 10-Q · filed 2024-08-01 | ||
| 2024-03-31 | $3.31M 10-Q · filed 2024-05-03 | |||
| 2023-12-31 | $2.09M 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $5.40M 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $1.83M 10-Q · filed 2022-11-02 | |||
| 2021-12-31 | $15.17M 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $6.77M 10-K · filed 2023-02-27 | |||
| 2019-12-31 | $20.02M 10-K · filed 2022-03-01 | |||
| 2018-12-31 | $9.82M 10-K · filed 2021-03-01 | |||
| 2017-12-31 | $33.07M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |